Related Experiment Video
Updated: Apr 9, 2026
Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Controlled Attenuation Parameter and Gallstone Disease Risk: A Retrospective Cohort Study with Mediation Analysis and
Xuan Bai1,2, Xiaofang Li3, Qiaoling Wang4
1Department of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, People's Republic of China.
Background:
The association between the controlled attenuation parameter (CAP)-a noninvasive marker for hepatic steatosis-and gallstone disease (GSD) remains poorly understood. This study aimed to investigate the impact of CAP levels and their longitudinal trajectories on GSD risk and explore potential mediating pathways.
Methods:
A dynamic cohort of 6,308 adults without baseline GSD underwent serial health examinations in Ya'an, China, from January 2020 to April 2025. The statistical methods included multivariate Cox regression analysis, restricted cubic spline (RCS) analysis, and mediation analysis. For sensitivity analyses, we performed gender-stratified analysis, trial sequential analysis (TSA), cumulative risk curve plotting, and re-analysis after excluding individuals with baseline diseases. Among 412 participants with ≥ 3 CAP measurements, group-based trajectory modelling (GBTM) identified CAP patterns and related them to GSD incidence.
Results:
Each 1-SD increase in CAP was associated with a 40% higher GSD risk, with a stronger association in women (HR = 1.96, P = 0.02) than in men (HR = 1.36, P = 0.04). RCS revealed a strictly linear dose-response relationship between CAP and GSD risk (P non-linear = 0.43). Compared with the reference group (CAP ≤ 238 dB/m), moderate (259-292 dB/m) and severe (> 292 dB/m) steatosis were associated with significantly higher GSD risk (HR = 2.56, P < 0.01; HR = 2.47, P = 0.01, respectively), whereas mild steatosis (238-259 dB/m) showed no significant association (P = 0.11). GBTM identified "persistently low" (61.41%) and "persistently high" (38.59%) CAP trajectories, with the latter group having a 3.85-fold higher GSD risk (P = 0.04). Mediation analysis identified a significant pathway from CAP to GSD via high-density lipoprotein cholesterol (HDL-C, P < 0.01, proportion of mediation = 27.49%).
Conclusion:
CAP is positively and linearly associated with GSD risk, particularly in women. Persistently high CAP levels confer a significantly elevated GSD risk. HDL-C is a significant mediator.
Related Concept Videos
01:27Urinary Tract Calculi IV: Nutrition Therapy and Prevention
01:25Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
01:30Urinary Tract Calculi III: Medical Management
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT